Navigation Links
Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008
Date:8/17/2008

Bruker Daltonics today is showcasing several new high performance mass spectrometry products and applications for proteomics at the 7th HUPO World Congress 2008:

AMSTERDAM, The Netherlands (Business Wire EON) August 17, 2008 -- maXis™ is the world's first high speed Ultra High Resolution TOF (UHR-TOF) mass spectrometer platform, and truly represents a revolution in tandem mass spectrometry. maXis offers exceptional proteomics performance with sub-ppm mass accuracy, mass resolution of 40,000 to 60,000 across a broad mass range, outstanding sensitivity and five orders of dynamic range - all at the high spectral rate of 20 Hz for MS and MS/MS that is essential for quantitative proteomics and to take full advantage of ultra-high performance liquid chromatography. ETD II is the next-generation electron transfer dissociation module for Bruker's HCTultra™ high capacity ion trap. It is based on a novel and compact nCI (negative chemical ionization) source with increased ETD/PTR reactant ion generation, resulting in rapid, confident characterization of PTMs such as phosphorylations or glycosylations at sub-fmol sensitivity. In combination with the major and fundamental ETD efficiency and sensitivity advantages of the spherical high capacity trap design, ETD II is designed to provide the most sensitive, fastest and most robust ETD fragmentation. Due to HCTultra's inherent m/z range of greater 3,000 and its superior mass resolution that can resolve 3+ and 4+ charge states of peptides on-the-fly at full analytical speed, ETD/PTR on the HCT-Ultra can even be used for up to 12 kDa proteins and beyond. MALDI-TDS™ Top-Down Sequencing (TDS) solution provides unparalleled levels of information from undigested proteins in pharmaceutical and biotechnology applications, including C- and N- terminal assignments even in the case of N-terminally blocked proteins. MALDI-TDS is available on Bruker's top-of-the line ultraflex™ III TOF/TOF system for the characterization of PEGylation sites and other protein modifications of vital importance in fields such as recombinant protein production, biologics drug development and quality control. MALDI-TDS has clearly proven its usefulness in the recent ABRF Protein Research Group (PRG) 2008 Study for the identification and differentiation of various truncated proteins of the same origin and provided 100% protein sequence coverage. Bruker's unique SmartBeam™ is the enabling technology for MALDI-TDS, complemented by next generation BioTools 3.2 top-down bioinformatics. The high sensitivity SmartBeam™ MALDI ion funnel source has now been coupled with the ultra-high mass resolution apex-ultra™ FTMS, representing a 'perfect match' for MALDI small molecule tissue imaging, including drugs and metabolites from animals dosed at therapeutic levels, e.g. at or below 5 mg/kg. With mass resolution greater than 900,000 (at 7 Tesla), the cluttered spectra produced in small molecule MALDI imaging of tissue samples are readily resolved, allowing for the first time MALDI-MS imaging of small molecules without the requirement to use MS/MS (SRM) for chemical background suppression. The high mass accuracy combined with Bruker's SmartFormula™ software automatically provides sum formula determination for detected molecules. This new imaging solution promises to advance areas such as drug development and delivery, clinical and pathology research, as well as other areas such as lipidomics. EASY-nLC™ is a Bruker-supported nanoscale LC system with 1D and 2D separation capabilities. Due to the true split-free gradient mixing it avoids cumbersome maintenance, and guarantees robust, steady and reliable operation. EASY-nLC dramatically reduces total solvent consumption and enables fast separations with peak widths less than 5 sec. The control by Bruker's Hystar™ software supports all proteomics applications on the maxis, micrOTOF-Q II, HCT ion trap, Flex MALDI and apex FTMS instrument series for complete, turn-key LC/MS/MS solutions. The new Bruker mass spectrometry products and applications for proteomics will be presented throughout the HUPO conference with more than 30 scientific contributions. During two Bruker Daltonics' luncheon seminars on Monday and Tuesday titled "(R)evolution in Biomarker Discovery", a prestigious researcher's panel including Helmut Meyer (MPC Bochum), Andrew Pitt (Univ. Glasgow) and Ron Heeren (FOM Amsterdam) will present talks detailing proteomics applications based on the novel developments.

Bruker Daltonics Executive Vice President Dr. Michael Schubert commented: "At this year's HUPO World Congress in Amsterdam, Bruker Daltonics is continuing its history of market leading innovations and is proudly releasing the maXis, an instrument with unprecedented, simultaneous high speed and ultra-high resolution performance across a broad mass range. In addition, Bruker Daltonics is greatly expanding the capabilities of its existing products through the release of several important enhancements, as well as new and innovative applications."

For further information on the HUPO conference, please see www.hupo2008.org.

For more information about Bruker Daltonics and Bruker Corporation (NASDAQ: BRKR), please visit www.bdal.com and www.bruker.com.

EASY-nLC(TM) is a trademark of Proxeon Biosystems, Denmark

MULTIMEDIA GALLERYhttp://www.businesswire.com/cgi-bin/mmg.cgi?eid=5757501

Read the full story at http://www.prweb.com/releases/bruker/maldi/prweb1219894.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement
2. Better Nutrition Announces Best Of Beauty Awards Winners Showcasing the Best Natural Beauty Products of 2008
3. NIH scientists find a novel mechanism that controls the development of autoimmunity
4. Sales of Emerging Novel Pain Therapies Will Represent More than One-Fifth of the Total Pain Drug Market by 2023
5. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
6. Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
7. Finding suggests novel ways to boost vaccination or natural defenses
8. Novel hydrogel systems for dentin regeneration
9. HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia (BPH) Product
10. Novel model of osteosarcoma
11. Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008 
(Date:8/22/2017)... , ... August 22, 2017 , ... “Call Of Spiritual ... is the creation of published author, C.S. Lizarde. Growing up on the streets ... trials. When Carlos began to apply the Biblical keys to his life, he ...
(Date:8/21/2017)... (PRWEB) , ... August 22, 2017 , ... ... but not without risk to health and safety. By learning and implementing best ... eliminated. , In this webinar, attendees will gain a better understanding of ...
(Date:8/21/2017)... ... August 21, 2017 , ... FCPX LUT Monochromatic Volume ... can quickly and easily add washed color grades to footage. A LUT is a ... every pixel’s color to the corresponding color indicated by the table. This pack comes ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... taking place all over the country. , Outdoor running increases exposure to ultraviolet ... at an increased risk of melanoma, and only half may be adequately protecting ...
(Date:8/21/2017)... ... August 21, 2017 , ... PIXACORE , an independent full-service agency with ... 100 agencies of the year by MM&M. , This is the first time PIXACORE ... milestone for the agency. PIXACORE’s newfound recognition reflects its steady trajectory of growth ...
Breaking Medicine News(10 mins):
(Date:8/11/2017)... Aug. 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), ... and big data solutions, today announced that it will ... 14 and host a conference call at 9:00am ET. ... and financial results and its strategy and outlook for ... by Erez Raphael , Chief Executive Officer, and ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/7/2017)... DUBLIN , Aug. 7, 2017  Endo International ... has reached agreements to resolve virtually all known U.S. ... in discussions to resolve the known remaining U.S. claims ... installment payments beginning in the fourth quarter of 2017 ... part of its second quarter 2017 results, the Company ...
Breaking Medicine Technology: